MFX

Private

StevenageHealthcare & Life Scienceshttps://mfx.bio/

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$2.61M

Company Overview

MFX is a biotechnology company that provides a scalable bioreactor and data platform for cell and gene therapy research, development, and manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

bioprocessingcell and gene therapyCGTbioreactorbiotech manufacturinglab automationmicrofluidicsprocess developmentCDMObio-manufacturingbiotech hardwarebioprocess analyticsautologous therapyallogeneic therapybiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MFX Comps

Public and private peers based on sector, stage, and business model.

MFX comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MFX Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Nov 19, 2025
Grant	Dec 19, 2023
VC Round	Dec 8, 2022
Seed	Apr 20, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Steve Gore

Chief Financial Officer

Executive Team

MFX Investors

Notable investors and investment history

MFX investors
Investor	Rounds
Innovate UK	Grant
Cambridge Angels	Seed
UK Innovation & Science Seed Fund	VC Round, Seed
Perscitus LLP	VC Round
88 Capital & Investments	Seed
Puffin Point	VC Round
Longwall Venture Partners	VC Round, Grant, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 17, 2025
Dr. Katy Newton appointed to lead innovation in cell-based therapies.

View all signals

MFX Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MFX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MFX's valuation, stock price, and market status.

Firmographic Details

HeadquartersStevenage

Employee Range42

Year Founded2018

Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.